Program
Sunday, 7 October 2012
18:30 Opening lecture
to be announced
to be announced
19:30 Welcome Aperitif
20:00 Dinner
Monday, 8 October 2012
Hepatitis E
08:30- 13:00 Morning session: plenary lectures
Chair:
M. A. Purdy, Centers for control and prevention, Atlanta, US
Current perspectives on HEV evolution
M. A. Purdy, Centers for control and prevention, Atlanta, US
Hepatitis E virus: replication and molecular biology
X.-J. Meng, Virginia Polytechnic Institute and State University, Blacksburg, US
Hepatitis E virus: neutralizing sites, diagnosis and protective immunity
J. Zhang, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen, China
HEV chronicity and transplants, HEV treatment
J. Izopet, CHU Rangueil, Toulouse, FR
13:00 Lunch
14:30 Afternoon session: abstract presentations and discussion around the poster boards
Tuesday, 9 October 2012
Hepatitis B
08:00- 12:30 Morning session: plenary lectures
Chairs: &
P. Arbuthnot, University of the Witwatersrand, Johannesburg, South Africa
F. Zoulim, INSERM U1052 University of Lyon 1, Lyon, FR
HBV replication and viral entry
S. Urban, University Hospital of Heidelberg, Heidelberg, DE
Insight from experimental models and clinical studies
F. Zoulim, INSERM U1052/University of Lyon 1, Lyon, FR
Novel insight in HBV - host interactions
U. Protzer, Technische Universität München / Helmholtz Zentrum München, München, DE
RNA interference-based treatment of HBV infection
P. Arbuthnot, University of the Witwatersrand, Johannesburg, South Africa
12:30 Lunch
14:00 Day Trip
Wednesday, 10 October 2012
Hepatitis C
08:30-13:00 Morning session: plenary lectures
Chairs:
T. F. Baumert, T. F. Baumert, INSERM 748 University of Stasbourg, FR
J. A. McKeating, College of Medical and Dental Sciences/University of Birmingham, Birmingham, UK
Molecular mechanisms of HCV entry
J. A. McKeating, College of Medical and Dental Sciences/University of Birmingham, Birmingham, UK
Clinical implications of HCV entry for liver disease and antiviral treatment
T. F. Baumert, INSERM 748 University of Stasbourg, FR
HCV treatment - perspectives and future challenges
H. Wedemeyer, Hannover Medical School, Hannover, DE
Host factors for viral HCV replication and assembly
V. Lohmann, University of Heidelberg, Heidelberg, DE
13:00 Lunch
14:30 Afternoon session: abstract presentations and discussion around the poster boards
Thursday, 11 October 2012
Bus leaving in Front of the Hotel Victoria to the Geneva airport early morning
